Rubin R. Despite Its Fan Base, Newly Authorized "Traditional" Novavax COVID-19 Vaccine Is Having Trouble Gaining a Foothold in the US. JAMA 2022 Aug 24. pii: 2795814. doi: 10.1001/jama.2022.13661.
PMID: 36001324